Development
Zimmer Biomet Holdings, Inc.
ZBH
$92.38
$0.460.50%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 7.39B | 7.28B | 7.20B | 7.11B | 6.94B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.39B | 7.28B | 7.20B | 7.11B | 6.94B |
| Cost of Revenue | 2.08B | 2.07B | 2.03B | 2.02B | 2.02B |
| Gross Profit | 5.31B | 5.21B | 5.16B | 5.09B | 4.92B |
| SG&A Expenses | 2.79B | 2.77B | 2.72B | 2.69B | 2.63B |
| Depreciation & Amortization | 561.50M | 548.10M | 534.60M | 529.40M | 526.80M |
| Other Operating Expenses | -- | 11.40M | 19.50M | 27.30M | 33.80M |
| Total Operating Expenses | 5.90B | 5.85B | 5.75B | 5.69B | 5.62B |
| Operating Income | 1.50B | 1.43B | 1.45B | 1.42B | 1.32B |
| Income Before Tax | 1.07B | 708.00M | 666.30M | 589.10M | 403.50M |
| Income Tax Expenses | 42.20M | 232.80M | 159.80M | 138.40M | 112.30M |
| Earnings from Continuing Operations | 1.03K | 475.20 | 506.50 | 450.70 | 291.20 |
| Earnings from Discontinued Operations | -- | 0.00 | 0.00 | 0.00 | -58.80M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.10M | -900.00K | -900.00K | -1.00M | -1.00M |
| Net Income | 1.02B | 474.30M | 505.60M | 449.70M | 231.40M |
| EBIT | 1.50B | 1.43B | 1.45B | 1.42B | 1.32B |
| EBITDA | 2.45B | 2.37B | 2.38B | 2.34B | 2.25B |
| EPS Basic | 4.91 | 2.27 | 2.42 | 2.15 | 1.10 |
| Normalized Basic EPS | 3.78 | 3.26 | 3.34 | 3.28 | 2.83 |
| EPS Diluted | 4.89 | 2.26 | 2.41 | 2.14 | 1.10 |
| Normalized Diluted EPS | 3.77 | 3.24 | 3.33 | 3.27 | 2.82 |
| Average Basic Shares Outstanding | 834.80M | 836.70M | 837.60M | 838.60M | 838.40M |
| Average Diluted Shares Outstanding | 838.90M | 840.10M | 840.40M | 840.80M | 840.50M |
| Dividend Per Share | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 |
| Payout Ratio | 19.62% | 42.40% | 39.81% | 44.76% | 86.95% |